Compare J M Smucker Co (SJM) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
J M Smucker Co vs Smith & Nephew plc — how do they compare? J M Smucker Co trades at $123.61 (market cap $13.17B), while Smith & Nephew plc trades at $27.96 (market cap $11.62B). The key difference: J M Smucker Co and Smith & Nephew plc are close in size by market cap, and J M Smucker Co pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| SJM | SNN | |
|---|---|---|
Market Cap | $13.17B | $11.62B |
Sector | Consumer Staples | Health |
52-Week High | $132.34 | $38.53 |
52-Week Low | $89.53 | $27.80 |
Enterprise Value | $20.03B | $14.66B |
Dividend Yield | 3.63% | 2.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SJM trades at $124.66, down 1.13% on the day, with a bullish technical signal from moving averages but bearish oscillators. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $3.24 surpassing the $2.22 estimate. The company reported a net loss of $1.23 billion for 2025, though revenue grew to $8.73 billion. Analyst consensus is a Buy with a $144.78 price target, indicating potential upside. A dividend of $1.12 per share is scheduled for payment on September 1, 2026.
The outlook is cautiously optimistic, driven by strong earnings performance and raised guidance, but high valuation ratios and recent insider sales pose risks. Debt levels remain elevated with a debt-to-asset ratio of 43.71% in 2025. Investors should weigh robust operational cash flow against margin pressures and competitive challenges in the consumer staples sector.
SNN trades at $27.87, down 3.46% today and near a 52-week low. Technical indicators are bearish, but oversold RSI levels suggest potential for a rebound. Fundamentally, the company shows strong revenue growth to $6.16 billion in 2025 and a net income margin of 10.08%, though recent guidance cuts and CFO departure have weighed on sentiment. A dividend of $0.31 is scheduled for payment in November 2026.
The outlook is cautious due to competitive pressures and execution risks, but valuation metrics like a P/E of 18.96 appear reasonable. Analyst consensus is Hold, with 65% recommending neutrality. Upside depends on improved operational performance and stabilization in key markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About J M Smucker Co
J.M. Smucker is a packaged food company that primarily operates in the U.S. retail channel (87% of fiscal 2022 revenue), but also in U.S. food-service (7%), and international (6%). Its largest segment is pet food and treats (36% of 2022 revenue), with popular brands such as Milk-Bone, Meow Mix, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Rachael Ray Nutrish. Its second-largest category is coffee (35% across channels) with the number-two brand Folgers and number-six Dunkin'. Other large categories are peanut butter (10%), with number-one Jif, fruit spreads (5%) with number-one Smucker's, and frozen hand-held foods (6%) with number-one Uncrustables.
Read more on SJM →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
